PUBLIC COMPANY
saveUniversity of California San Diego
updated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
36
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Syphilis spreads while researchers contend with federal constraints and a drug shortageAt the San Diego-Tijuana border, syphilis spreads while researchers contend with federal constraints and a drug shortage.stat · 20d ago
- Dr McCann on the FDA Approval of Vepdegestrant for ESR1-Mutated, ER+ Advanced Breast CancerKelly Elizabeth McCann, MD, PhD, notes the role of vepdegestrant in the ESR1-mutated, ER-positive, HER2-negative advanced breast cancer treatment paradigm.onclive · 3mo ago
comments(0)
5-min edit window · permanent after that